17-76391202-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_022066.4(UBE2O):c.3620G>A(p.Gly1207Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000205 in 1,460,792 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G1207S) has been classified as Likely benign.
Frequency
Consequence
NM_022066.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UBE2O | NM_022066.4 | c.3620G>A | p.Gly1207Asp | missense_variant | 18/18 | ENST00000319380.12 | NP_071349.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UBE2O | ENST00000319380.12 | c.3620G>A | p.Gly1207Asp | missense_variant | 18/18 | 1 | NM_022066.4 | ENSP00000323687.6 | ||
UBE2O | ENST00000587127.1 | c.2162G>A | p.Gly721Asp | missense_variant | 10/10 | 1 | ENSP00000468498.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250762Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135502
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1460792Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 726578
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 13, 2022 | The c.3620G>A (p.G1207D) alteration is located in exon 18 (coding exon 18) of the UBE2O gene. This alteration results from a G to A substitution at nucleotide position 3620, causing the glycine (G) at amino acid position 1207 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at